Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves and Second Trabeculectomy in Glaucoma Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00665756|
Recruitment Status : Unknown
Verified April 2008 by Federal University of São Paulo.
Recruitment status was: Active, not recruiting
First Posted : April 24, 2008
Last Update Posted : April 24, 2008
|Condition or disease||Intervention/treatment||Phase|
|Open Angle Glaucoma||Procedure: second Trabeculectomy Procedure: Ahmed Implant||Not Applicable|
In the management of open angle glaucoma, frequently more then one procedure is necessary to control the intra ocular pressure. There is still no consensus whether this second intervention should be a second trabeculectomy or a shunt device. In the present study we compare a second trabeculectomy versus Ahmed silicone shunt device in open angle glaucoma patients with previous trabeculectomy without proper IOP control.
40 Patients with clinically uncontrolled open angle glaucoma with previous trabeculectomy surgery were selected from the glaucoma sector of Federal university of Sao Paulo. Patients were randomized to one of two groups:
- Silicone Ahmed Implant
- Second trabeculectomy
Ahmed silicone tube implant: A fornix-based conjunctival flap was created between two adjacent recti muscles. Before placement of the tube implant body to the sclera, tube was irrigated with saline solution to open the valve mechanism. The implant's polypropylene body was sutured to sclera with 6.0 silk suture. The tube then trimmed and the anterior chamber was entered from 1mm posterior to corneoscleral limbus with 23-gauge needle. A human donor scleral flap was placed over the tube and sutured to the sclera with 10.0 nylon suture. The conjunctiva was sutured to the limbus.
Second Trabeculectomy: A fornix-based conjunctival flap was created in the opposite superior quadrant of the previous trabeculectomy. Mitomycin-C was used under the conjunctival flap for up to 4 minutes (0,3mg/mL) and rinsed with 30mL saline solution. Scleral flap with crescent bevel and sclerectomy with a punch. Iridectomy and flap suture with nylon 10-0. Conjunctival suture with nylon 10-0.
Follow up after surgery was in the 1st, 4th, 7th, 15th, 30th days and after that monthly or whenever needed for clinical reasons.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves and Second Trabeculectomy in Glaucoma Patients|
|Study Start Date :||January 2006|
|Actual Primary Completion Date :||April 2008|
|Estimated Study Completion Date :||July 2008|
Active Comparator: 1
Procedure: second Trabeculectomy
second trabeculectomy with mitomycin-c
Other Name: re-Trabeculectomy with mitomycin-C
Active Comparator: 2
Ahmed silicone drainage device implantation
Procedure: Ahmed Implant
Ahmed silicone drainage device
Other Name: Armed FP-7 adult silicone valve
- intra ocular pressure [ Time Frame: Monthly ]
- number of hypotensive medications [ Time Frame: monthly ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00665756
|Federal University of Sao Paulo|
|Sao Paulo, SP, Brazil, 04023-062|
|Principal Investigator:||Augusto Paranhos JR, PHD||Federal University of Sao Paulo|